- Home
- SQFT vs PTIX Comparison
SQFT vs PTIX Comparison
Compare SQFT & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- PTIX
- Stock Information
- Founded
- SQFT 1999
- PTIX 1994
- Country
- SQFT United States
- PTIX United States
- Employees
- SQFT N/A
- PTIX N/A
- Industry
- SQFT Real Estate Investment Trusts
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- PTIX Health Care
- Exchange
- SQFT Nasdaq
- PTIX Nasdaq
- Market Cap
- SQFT 7.7M
- PTIX 6.3M
- IPO Year
- SQFT 2020
- PTIX 2016
- Fundamental
- Price
- SQFT $5.59
- PTIX $3.45
- Analyst Decision
- SQFT
- PTIX
- Analyst Count
- SQFT 0
- PTIX 0
- Target Price
- SQFT N/A
- PTIX N/A
- AVG Volume (30 Days)
- SQFT 988.5K
- PTIX 98.5K
- Earning Date
- SQFT 11-11-2025
- PTIX 11-13-2025
- Dividend Yield
- SQFT N/A
- PTIX N/A
- EPS Growth
- SQFT N/A
- PTIX N/A
- EPS
- SQFT N/A
- PTIX N/A
- Revenue
- SQFT $18,052,597.00
- PTIX N/A
- Revenue This Year
- SQFT $23.63
- PTIX N/A
- Revenue Next Year
- SQFT N/A
- PTIX N/A
- P/E Ratio
- SQFT N/A
- PTIX N/A
- Revenue Growth
- SQFT N/A
- PTIX N/A
- 52 Week Low
- SQFT $4.19
- PTIX $2.25
- 52 Week High
- SQFT $23.00
- PTIX $15.26
- Technical
- Relative Strength Index (RSI)
- SQFT 47.62
- PTIX 48.75
- Support Level
- SQFT $5.20
- PTIX $3.22
- Resistance Level
- SQFT $6.22
- PTIX $3.53
- Average True Range (ATR)
- SQFT 0.52
- PTIX 0.29
- MACD
- SQFT -0.07
- PTIX -0.07
- Stochastic Oscillator
- SQFT 25.47
- PTIX 21.09
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.